A Conserved Mito-Cytosolic Translational Balance Links Two Longevity Pathways.
Level 5 - mechanism / opinion, no new human data
Preclinical mechanistic bench and animal study (C. elegans, mouse models, mammalian cell culture)
PubMed 32084377 · doi:10.1016/j.cmet.2020.01.011
What was done
The authors evaluated correlations between mitochondrial and cytosolic ribosomal proteins in mouse population genetics datasets. In C. elegans, mitochondrial translation was inhibited via mrps-5 RNAi to assess downstream effects via integrated transcriptomics and proteomics, as well as genetic dependence on atf-5. The mechanism was further evaluated in mammalian cell culture and in the livers of germ-free mice using doxycycline to pharmacologically inhibit mitochondrial translation.
What was found
The abstract reports no numerical values, confidence intervals, or effect sizes. Qualitatively, natural co-regulation between mitochondrial and cytosolic ribosomal proteins was identified in mouse genetics. Experimentally, inhibiting mitochondrial translation in C. elegans reduced the translational efficiency of growth-pathway mRNAs, increased stress-response mRNAs, repressed cytosolic translation, and extended lifespan in an atf-5-dependent but metabolically independent manner. Pharmacological inhibition with doxycycline similarly repressed cytosolic translation in mammalian cells and germ-free mouse liver tissue.
Why it matters
This study describes a conserved cross-compartmental signaling axis linking mitochondrial and cytosolic translation via atf-5/ATF4. It integrates two previously separate longevity pathways into a unified mechanism of translational control.
Limits
No sample sizes, quantitative metrics, or variance statistics are provided in the abstract. The findings are restricted to in vitro and non-human animal models (nematodes and mice), so efficacy, safety, and translatability to human longevity are unestablished.
Cited by
- supports Preclinical studies in worms demonstrate that mitochondrial translation signals to cytosolic translation factors that regulate protein synthesis via an ATF4-dependent pathway.